Clinical Trials · NCT01708044

Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM

Name: Effect of Different Fixed Pramlintide:Insulin Dose Ratios on Postprandial Glucose in T1DM
Creator: Peptide Science Daily
License: https://clinicaltrials.gov/about-site/terms-conditions

CompletedPhase 1Pramlintide

Phase: Phase 1
Recruitment status: Completed
Sponsor: AstraZeneca
Enrollment: 32
Start date: Nov 2012
Locations: 1 site, United States
Primary endpoint: Incremental area under the concentration-time curve (AUC(0-3 h)) of plasma glucose concentrations for each treatment

View Pramlintide compound reference